XML 42 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Data (Tables)
 12 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Financial Information for Company's Segments
(Millions of dollars)
2017
 
2016
 
2015
 
Revenues (A)
 
 
 
 
 
 
Medical
$
8,105

 
$
8,654

 
$
6,460

 
Life Sciences
3,988

 
3,829

 
3,822

 
Total Revenues
$
12,093

 
$
12,483

 
$
10,282

 
Income Before Income Taxes
 
 
 
 
 
 
Medical
$
2,155

 
$
2,052

 
$
1,530

 
Life Sciences
772

 
793

 
839

 
Total Segment Operating Income
2,927

 
2,845

 
2,368

 
Acquisitions and other restructurings
(354
)
 
(728
)
 
(426
)
 
Net interest expense
(445
)
 
(367
)
 
(356
)
 
Other unallocated items (B)
(1,152
)
 
(676
)

(847
)
 
Income Before Income Taxes
$
976

  
$
1,074

 
$
739

 
Segment Assets
 
 
 
 
 
 
Medical
$
18,332

  
$
19,154

  
$
20,055

 
Life Sciences
4,056

  
3,848

  
3,932

 
Total Segment Assets
22,388

  
23,002

  
23,987

 
Corporate and All Other (C)
15,347

  
2,584

  
2,491

 
Total Assets
$
37,734

  
$
25,586

  
$
26,478

 
Capital Expenditures
 
 
 
 
 
 
Medical
$
502

  
$
482

  
$
414

 
Life Sciences
212

  
200

  
168

 
Corporate and All Other
13

  
12

  
14

 
Total Capital Expenditures
$
727

  
$
693

  
$
596

 
Depreciation and Amortization
 
 
 
 
 
 
Medical
$
825

  
$
857

  
$
619

 
Life Sciences
254

  
254

  
256

 
Corporate and All Other
10

  
3

  
17

 
Total Depreciation and Amortization
$
1,088

  
$
1,114

  
$
891

 

(A)Intersegment revenues are not material.
(B)Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. Results in 2017 included a $748 million non-cash charge resulting from a modification to the Company's dispensing equipment lease contracts with customers, as well as a $336 million reversal of certain reserves related to an appellate court decision which, among other things, reversed an unfavorable antitrust judgment in the RTI case. Additional disclosures regarding the legal matter and the lease contract modification are provided in Notes 5 and 17, respectively. Results in 2015 reflected $293 million in recognition of the fair value step-up adjustment recorded relative to CareFusion’s inventory on the acquisition date.
(C)Includes cash and investments and corporate assets.
Revenues to Unaffiliated Customers and Long-lived Assets Including Property, Plant and Equipment
Revenues to unaffiliated customers are generally based upon the source of the product shipment. Long-lived assets, which include net property, plant and equipment, are based upon physical location.
(Millions of dollars)
2017
 
2016
 
2015
Revenues
 
 
 
 
 
United States
$
6,504

 
$
6,893

 
$
5,069

Europe
2,588

 
2,674

 
2,434

Greater Asia
1,744

 
1,692

 
1,545

Other
1,257

 
1,225

 
1,234

 
$
12,093

 
$
12,483

 
$
10,282

Long-Lived Assets
 
 
 
 
 
United States
$
13,151

 
$
14,075

 
$
15,513

Europe
4,421

 
3,747

 
3,908

Greater Asia
578

 
586

 
573

Other
584

 
483

 
494

Corporate
366

 
329

 
332

 
$
19,101

 
$
19,220

 
$
20,819